Table 2.
Cardiometabolic and inflammatory profiles of GS patient COVID-19 positive compared to a control patient at time of discharge.
| Variables | Reference range | Covid-19 with GS | Covid-19 patient | % Difference |
|---|---|---|---|---|
| BMI (kg/m2) | 20–25 | 32.65 | 34.71 | 6.11 |
| SBP (mmHg) | 110–120 | 119 | 143 | 18.32 |
| DBP (mmHg) | 70–90 | 79 | 82 | 3.72 |
| Covid-19 IgM (U/mL) | 0.9–1.1 | 0.9 | 0.89 | 1.11 |
| Covid-19 IgG (U/mL) | 0.9–1.1 | 7.84 | 6.01 | 26.42 |
| SaO2% | 95–99 | 98 | 95 | 3.10 |
| TSB (mg/dL) | 0.2–1.0 | 3.4 | 0.8 | 123.81 |
| Conjugated bilirubin (mg/dL) | 0.1–0.3 | 0.4 | 0.7 | 54.54 |
| Un-conjugated bilirubin (mg/dL) | 0.1–0.7 | 3.0 | 0.1 | 187.09 |
| FBG (mg/dL) | 70–90 | 95 | 179 | 61.31 |
| HbA1c (%) | 4.5–5.5 | 5.5 | 5.9 | 7.01 |
| Blood urea | 20–40 | 33 | 34.7 | 5.02 |
| Serum creatinine | 0.5–1.5 | 1.3 | 1.2 | 8 |
| CRP (mg/L) | 0.5–200 | 22 | 122 | 138.88 |
| D-dimer (ng/mL) | 50–10.000 | 452 | 631.71 | 33.16 |
| Ferritin (ng/mL) | 20–250 | 105 | 207.84 | 65.74 |
| LDH (U/L) | 230–460 | 321 | 395.21 | 20.72 |
| Hb (g/dL) | 12–14 | 13.8 | 14.36 | 3.97 |
| WBC (μ/L) | 4,000–11,000 | 8.832 | 9.44 | 6.65 |
| Lymphocytes % | 20–40 | 33.7 | 22.53 | 39.72 |
| Neutophils % | 40–80 | 72.88 | 80.45 | 9.87 |
| Radiological score | 1–5 | 1 | 2 | 66.66 |
Data presented as number and %, BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; TSB, total serum bilirubin; FBG, fasting blood glucose; HbA1c, glycated hemoglobin.